Water-Guzzling Benefits Don't Wash

Related Newser Stories

• 10K in Zimbabwe Hit by Cholera: UN

  Nov 30, 08 3:31 PM CST
  The UN says more than 400 Zimbabweans have died and 10,000 are ill as a result of cholera, the London Telegraph reports. But critics like opposition leader Morgan Tsvangirai accuse the government of fudging even those high numbers, insisting that more than 500 have died and half a million are sick. The unprecedented outbreak has spread from rural to urban Zimbabwe as clean water becomes less and less accessible under a collapsing infrastructure.
  More »

• Doctors See Rise in Kids With Kidney Stones

  Oct 28, 08 1:14 PM CDT
  Once associated with middle age, kidney stones are growing more common among US children, the New York Times reports. A few decades ago, physicians would “see a kid with a stone once every few months,” says one doctor. “Now we see kids once a week or less.” The increase comes from factors like salty diets and drinking too little water; some doctors link the stones to childhood obesity.
  More »

• 'Stayin' Alive' in Rhythm With CPR

  Oct 16, 08 5:54 PM CDT
  Disco may be dead, but it can still help others live. So say University of Illinois researchers, who found that med students performed CPR more effectively to the beat of the Bee Gees classic “Stayin’ Alive,” notes the Health Blog of the Wall Street Journal. Seems the song has 103 beats per minute, and CPR guidelines call for 100 compressions per minute.
  More »

• Leading Supplements Don't Slow Arthritis: Study

  Sep 30, 08 3:50 PM CDT
  Popular nutritional supplements glucosamine and chondroitin sulfate don’t slow the progression of arthritis, a 2-year study finds. Though a combination of the two is the nation's sixth-highest-selling dietary supplement, they didn’t cut cartilage loss any better than sugar pills in osteoarthritis patients, reports USA Today, confirming the findings of earlier research.
  More »

• Pharma Under Fire Over Pricey Drugs for Kids

  Jul 27, 08 7:37 AM CDT
  In the face of astronomical hikes in the price of drugs used to treat children, a congressional committee is looking into why companies have increased prescription costs as much as 18-fold when related research and marketing expenses are stable, according to lawmakers. One such company charges $69,000 for a three-vial drug treating infantile spasms—while a $15 alternative exists, reports Portfolio.
  More »